Stock Taper 
SECTORAL ASSET MANAGEMENT INC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Danaher Corporation | DHR | 9.6K | $1.83M |
 BioMarin Pharmaceutical Inc. | BMRN | 9.45K | $540.73K |
 Amgen Inc. | AMGN | 9.21K | $3.34M |
 Hinge Health, Inc. | HNGE | 8.74K | $725.75K |
 PTC Therapeutics, Inc. | PTCT | 7.47K | $609.33K |
 Royalty Pharma plc | RPRX | 7.2K | $403.7K |
 Ionis Pharmaceuticals, Inc. | IONS | 7.2K | $570.89K |
 Stryker Corporation | SYK | 7.13K | $2.25M |
 Eli Lilly and Company | LLY | 6.35K | $7.62M |
 Intuitive Surgical, Inc. | ISRG | 5.85K | $2.33M |
 Vertex Pharmaceuticals Incorporated | VRTX | 5.43K | $2.7M |
 Moderna, Inc. | MRNA | 4.35K | $304.63K |
 BridgeBio Pharma, Inc. | BBIO | 4.1K | $305.37K |
 Tempus AI, Inc. | TEM | 3.88K | $224.77K |
 Thermo Fisher Scientific Inc. | TMO | 3.51K | $1.76M |
 argenx SE | ARGX | 2.83K | $2.63M |
 Ascendis Pharma A/S | ASND | 2.57K | $685.47K |
 Incyte Corporation | INCY | 2.35K | $266.4K |
 Abivax S.A. | ABVX | 2.34K | $311.83K |
 Alnylam Pharmaceuticals, Inc. | ALNY | 2.31K | $695.38K |